- Jared Adelstein joins AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) Board of Directors, strengthening governance and commercialization efforts.
- AIML focuses on AI-powered healthcare solutions through subsidiaries and strategic partnerships.
- AIML stock is traded on multiple exchanges, including CSE, OTCQB, and Frankfurt Stock Exchange.
In a strategic move to bolster its governance and accelerate commercialization in the AI-powered healthcare sector, AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has appointed Jared Adelstein to its Board of Directors, effective immediately. This addition aligns with AIML's mission to deliver innovative healthcare solutions through artificial intelligence and machine learning.
Adelstein's expertise in guiding high-growth companies through critical developmental stages is expected to be instrumental for AIML as the company focuses on expanding its digital health and wellbeing solutions. "We are delighted to welcome Jared to our Board. His strategic insight and proven experience will be invaluable as we continue to scale AIML," said Paul Duffy, CEO of AIML.
AIML operates through its subsidiaries Quantum Sciences, NeuralCloud Solutions Inc., and AI Rx Inc., and holds a 95.2% stake in Health Gauge Inc. The company's strategic focus includes leveraging AI and ML, cloud computing, and digital platforms to drive healthcare management solutions and precision support across the health continuum.
AIML's shares are accessible to a broad range of investors, being listed on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market as "AIMLF", and the Frankfurt Stock Exchange as "42FB". The appointment of Adelstein is seen as a significant step forward in realizing AIML's vision of delivering breakthrough solutions at the intersection of AI and human health.
